Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.

NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck‘s stock, according to Citi.

Post a Comment